The BSAC  Drug Stability Testing Programme is part of the BSAC UK OPAT initiative. This programme is a key component to addressing antimicrobial stewardship within the BSAC OPAT programme and exists to provide evidence on the stability of drugs and devices used in infection management practice, particularly those used in Outpatient Parenteral Antimicrobial Therapy (OPAT) services.

Stability data generated by this programme has recently been published for Flucloxacillin and Meropenem. All data is open access and compliant with the latest NHS Pharmaceutical Quality Assurance Committee Yellow Cover Document (YCD) requirements.

The BSAC is seeking input on which drugs should be tested within this programme, we would like to hear your views on antimicrobial drugs you would consider using in your OPAT Service if more stability information was available to you.

We suggest that you discuss and complete this survey as an OPAT service (ideally with clinician, nurse and pharmacy input). A document is attached here: BSAC Drug Stability Survey Questions for participants, giving visibility of all questions in order to allow you to print these for review with OPAT colleagues.

There are 9 questions and the survey should take less than 10 minutes to complete. To participate in the survey please click here.

Deadline for responses: Friday 5 July 2019.

We look forward to receiving your suggestions and thank you in advance for your participation and feedback.

Dr Conor Jamieson (PhD)
Chair of the BSAC Drug Stability Testing Working Group
(On behalf of the BSAC Drug Stability Working Party)